A federal appeals court approved a settlement between the House Republicans and the Trump administration, ending a lawsuit over cost-sharing reduction payments for the Obamacare exchanges.
New York and Minnesota officials have settled a lawsuit against the Trump administration over its decision to slash federal funding for the states' health plan programs that cover certain low-income people.
The ACLU and state Planned Parenthood affiliates sued the Trump administration over changes to criteria for Title X family planning grants.
HHS wants the U.S. Supreme Court to review a ruling that questions whether Medicare Advantage patients should factor into a provider's disproportionate-share hospital payment.
A federal judge dismissed physician staffing firm Envision Healthcare's lawsuit against UnitedHealth Group over a payment dispute, saying it belongs in arbitration.
Atrium Health will release Mecklenburg Medical Group physicians from noncompete provisions and allow them to form their own practice.
A small number of hospitals and health systems are turning to the courts to challenge Anthem's new policies restricting outpatient imaging and emergency department coverage. Attorneys and industry experts disagree on the cases' merits.
A federal judge rejected the government's argument that insurers shouldn't be grouped together in the suit over cost-sharing reduction payments because their alleged damages would vary.
Henry Ford Health revealed last week that its insurance arm owes $12.7 million to a subsidiary's CEO as part of a proposed stock purchase.
Public health scholars are joining the fray to block Medicaid work requirements before they take effect in three red expansion states, claiming the coverage rollback undermines the program's mission and will hurt state health systems.
A federal judge in Alabama ruled that Blue Cross and Blue Shield plans' practice of creating exclusive territories could directly violate antitrust law.
Omni Healthcare is suing the wholesale drug distributor McKesson on behalf of the federal government and 30 states for allegedly repackaging cancer drugs from single-use vials, leading to fraudulent payments and serious infections.